Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Aspira Pathlab & Diagnostics Board Meeting Date

Aspira Pathlab & Diagnostics will hold a board meeting on November 6, 2026 to consider unaudited standalone results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.

Source

BSE filing, NSE: ASPIRA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aspira Pathlab & Diagnostics Ltd: key numbers

Share price
₹133.80
Market cap
₹137.7 Cr
Revenue (annual)
₹24.98 Cr
Net profit (annual)
₹0.05 Cr
P/E (TTM)
-304.3×Sector 52.8×
Promoter holding
46.65%+0.07% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aspira Pathlab & Diagnostics Ltd

All →

Other board meeting date announcements

All →